By David Tuller, DrPH A British study of neurological sequelae in patients many months after hospitalization for COVID-19 has found that “post acute cognitive deficits…were associated with elevated brain injury markers in serum and reduced grey matter volume,” according to a pre-print posted earlier this week. (A pre-print is a paper that has not yet …
By David Tuller, DrPH In the early months of the coronavirus pandemic, journalist Ed Yong played a key role in alerting the public to the wave of people suffering prolonged symptoms after an acute bout of COVID-19—the phenomenon that has come to be called long Covid. Yong, who won a Pulitzer Prize for his coronavirus …
Trial By Error: An Interview with Journalist Ed Yong Read More »
By David Tuller, DrPH Earlier this month, Betsy Ladyzhets and Miles Griffis, two smart, young American journalists, announced the launch The Sick Times, an online publication focused on long Covid and related post-acute infection syndromes, including ME/CFS. I have met both of them in the last couple of years and have been impressed with their …
Trial By Error: Interview with Founders of The Sick Times, a New Online Publication Read More »
By David Tuller, DrPH I’ve posted two past interviews with David Putrino (here and here) about long Covid, ME/CFS, and related issues. Dr Putrino, a neuroscientist and physical therapist, is director of rehabilitation innovation at the Mt Sinai Health System in New York. Early in the pandemic, the rehabiliation center he directs began seeing patients …
Trial By Error: David Putrino on New Nature Study of Long Covid Immune Profiling Read More »
By David Tuller, DrPH Akiko Iwasaki, a professor of immunobiology at the Yale School of Medicine, is a leading investigator into long Covid and has recently been tapped to lead a new Center for Infection & Immunity. She was elected to the National Academy of Sciences in 2018, the National Academy of Medicine in 2019, …
Trial By Error: An Interview with Yale’s Akiko Iwasaki Read More »
By David Tuller, DrPH I recently wrote about a Dutch study published a few months ago in the journal Clinical Infectious Diseases–“Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial.” The study, nick-named ReCOVer, found that unblinded trials relying on subjective outcomes will produce modestly positive reports …
